20:29 , Jul 16, 2019 |  BC Extra  |  Financial News

July 16 Financial Quick Takes: J&J growth drivers beat consensus; plus Notable and Cradle raise funds

Imbruvica, Darzalex sales top analysts' consensus  In its 2Q19 earnings report, Johnson & Johnson (NYSE:JNJ) said revenue from its pharmaceutical segment grew to $10.53 billion during the quarter, up 1.7% compared with 2Q18, with newer...
02:31 , May 18, 2018 |  BC Week In Review  |  Company News

Illumina shells out $100M for Edico Genome acquisition

Illumina Inc. (NASDAQ:ILMN) will acquire genome analytics company Edico Genome Inc. (La Jolla, Calif.) for $100 million. SVP of Product Development Susan Tousi told BioCentury that Illumina will use Edico's DRAGEN Bio-IT Platform to accelerate...
21:44 , May 15, 2018 |  BC Extra  |  Company News

Illumina to acquire Edico for $100M

Illumina Inc. (NASDAQ:ILMN) will acquire genome analytics company Edico Genome Inc. (La Jolla, Calif.) for $100 million. SVP of Product Development Susan Tousi told BioCentury that Illumina will use Edico's DRAGEN Bio-IT Platform to accelerate...
01:50 , May 13, 2017 |  BioCentury  |  Finance

Ready to ramp

A day after emerging from stealth mode, strategic investor Dell Technologies Capital backed Edico Genome Inc. to ramp up the launch of a bioinformatics processor used to analyze sequencing data. The VC led Edico’s $22...
05:40 , May 12, 2017 |  BC Week In Review  |  Financial News

Edico Genome completes $22M series B round

On May 9, genome sequencing company Edico Genome Inc. (La Jolla, Calif.) raised $22 million in a series B round led by new investor Dell Technologies Capital, the venture arm of Dell Technologies Inc. (NYSE:DVMT)....
21:49 , May 9, 2017 |  BC Extra  |  Financial News

Edico raises $22M in series B

Edico Genome Inc. (San Diego, Calif.) raised $22 million in a series B financing led by new investor Dell Technologies Capital, the venture arm of Dell Technologies Inc. (NYSE:DVMT). Existing investors Qualcomm Ventures, Axon Ventures...
08:00 , Jan 19, 2015 |  BC Week In Review  |  Financial News

Obalon Therapeutics completes venture financing

Obalon Therapeutics Inc. , Carlsbad, Calif.   Business: Endocrine/Metabolic   Date completed: 2015-01-14   Type: Venture financing   Raised: $20 million   Investors: Axon Ventures; Bader Sultan & Bros.; Mirae Asset Venture Investment; NeoPlux; Striker...
07:00 , Jul 21, 2014 |  BC Week In Review  |  Financial News

Edico Genome completes venture financing

Edico Genome Inc. , La Jolla, Calif.   Business: Genomics   Date completed: 2014-07-17   Type: Venture financing   Raised: $10 million   Investors: Qualcomm Ventures; Axon Ventures; and an individual investor  ...
07:00 , Jul 21, 2014 |  BioCentury  |  Emerging Company Profile

Edico: Processing genomes

Next-generation sequencing technologies have reduced the time and cost to sequence whole genomes, but the computational time and resources needed to analyze the resulting data remain a bottleneck. Edico Genome Inc. is developing a processor...
00:23 , Jul 18, 2014 |  BC Extra  |  Financial News

Edico raises $10 million in A round

Edico Genome Inc. (La Jolla, Calif.) raised $10 million in a series A round led by Qualcomm Ventures. Axon Ventures and Gregory Lucier also participated. Edico is developing its Dragen Bio-IT processor, which reduces the...